The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Evolutionary Rationale for Phages as Complements of Antibiotics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic resistance-the need for global solutions
Laxminarayan, R., Duse, A., Wattal, C., Zaidi, A. K. M., Wertheim, H. F. L., Sumpradit, N., Vlieghe, E., Hara, G. L., Gould, I. M., Goossens, H., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70318-9 · Cited by 4,439
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Interactive and cumulative effects of multiple human stressors in marine systems
Crain, C. M., Kroeker, K., & Halpern, B. S. (2008) · Ecology Letters · doi:10.1111/j.1461-0248.2008.01253.x · Cited by 2,141
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,425
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria
Pagès, J.-M., James, C. E., & Winterhalter, M. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1994 · Cited by 939
Wright, A., Hawkins, C. H., Änggård, E. E., & Harper, D. R. (2009) · Clinical Otolaryngology · doi:10.1111/j.1749-4486.2009.01973.x · Cited by 864
Reconceptualizing synergism and antagonism among multiple stressors
Piggott, J. J., Townsend, C. R., & Matthaei, C. D. (2015) · Ecology and Evolution · doi:10.1002/ece3.1465 · Cited by 678
Combination approaches to combat multidrug-resistant bacteria
Worthington, R. J., & Melander, C. (2013) · Trends in Biotechnology · doi:10.1016/j.tibtech.2012.12.006 · Cited by 625
Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy
Lu, T. K., & Collins, J. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800442106 · Cited by 529
Population and evolutionary dynamics of phage therapy
Levin, B. R., & Bull, J. J. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro822 · Cited by 511
Phage-Antibiotic Synergy (PAS): β-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth
Comeau, A., Tétart, F., Trojet, S. N., Prère, M. F., & Krisch, H. M. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000799 · Cited by 488
Bacteriophages as potential new therapeutics to replace or supplement antibiotics
Kutateladze, M., & Adamia, R. (2010) · Trends in Biotechnology · doi:10.1016/j.tibtech.2010.08.001 · Cited by 483
Antiretroviral therapy and management of HIV infection
Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 449
Phage Therapy—History from Twort and d'Herelle Through Soviet Experience to Current Approaches
Chanishvili, N. (2012) · Advances in Virus Research · doi:10.1016/b978-0-12-394438-2.00001-3 · Cited by 407
Phage Therapy in the Food Industry
Endersen, L., O'Mahony, J., Hill, C., Ross, R. P., McAuliffe, O., & Coffey, A. (2014) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-030713-092415 · Cited by 338
Revisiting phage therapy: new applications for old resources
Nobrega, F. L., Costa, A. R., Kluskens, L. D., & Azeredo, J. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.01.006 · Cited by 310
Antimicrobial Resistance in Developing Countries
(2010) · DIAL (Catholic University of Leuven) · doi:10.1007/978-0-387-89370-9 · Cited by 275
The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy
Read, A. F., Day, T., & Huijben, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100299108 · Cited by 242
Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro
Ryan, E. M., Alkawareek, M. Y., Donnelly, R. F., & Gilmore, B. F. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00977.x · Cited by 240
Baharoglu, Z., & Mazel, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01549-10 · Cited by 240
Antibiotic resistance sweeping developing world
Reardon, S. (2014) · Nature · doi:10.1038/509141a · Cited by 230
Kamal, F., & Dennis, J. J. (2015) · Applied and Environmental Microbiology · doi:10.1128/aem.02850-14 · Cited by 224
Pena-Miller, R., Laehnemann, D., Jansen, G., Fuentes-Hernandez, A., Rosenstiel, P., Schulenburg, H., & Beardmore, R. (2013) · PLoS Biology · doi:10.1371/journal.pbio.1001540 · Cited by 209
Chhibber, S., Kaur, T., & Kaur, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056022 · Cited by 204
Cystobactamids: Myxobacterial Topoisomerase Inhibitors Exhibiting Potent Antibacterial Activity
Baumann, S., Herrmann, J., Raju, R., Steinmetz, H., Mohr, K. I., Hüttel, S., Harmrolfs, K., Stadler, M., & Müller, R. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201409964 · Cited by 176
Nichol, D., Jeavons, P., Fletcher, A. G., Bonomo, R. A., Maini, P. K., Paul, J. L., Gatenby, R. A., Anderson, A. R. A., & Scott, J. G. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004493 · Cited by 170
Fitness cost of antibiotic susceptibility during bacterial infection
Roux, D., Danilchanka, O., Guillard, T., Cattoir, V., Aschard, H., Fu, Y., Angoulvant, F., Messika, J., Ricard, J.-D., Mekalanos, J. J., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab1621 · Cited by 169
Torres-Barceló, C., Arias-Sánchez, F. I., Vasse, M., Ramsayer, J., Kaltz, O., & Hochberg, M. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106628 · Cited by 166
Self-citationJousset, A., Rochat, L., Péchy-Tarr, M., Keel, C., Scheu, S., & Bonkowski, M. (2009) · The ISME Journal · doi:10.1038/ismej.2009.26 · Cited by 166
Phage–host interplay: examples from tailed phages and Gram-negative bacterial pathogens
Chaturongakul, S., & Ounjai, P. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00442 · Cited by 165
Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa
Knezevic, P., Curcin, S., Aleksic, V., Petrusic, M., & Vlaski, L. (2013) · Research in Microbiology · doi:10.1016/j.resmic.2012.08.008 · Cited by 159
Lehman, S. M., & Donlan, R. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03786-14 · Cited by 156
The gyrase inhibitor albicidin consists of p-aminobenzoic acids and cyanoalanine
Cociancich, S., Pesic, A., Petras, D., Uhlmann, S., Kretz, J., Schubert, V., Vieweg, L., Duplan, S., Marguerettaz, M., Noëll, J., et al. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1734 · Cited by 143
HUFF, W. E., Huff, G. R., Rath, N. C., BALOG, J. M., & Donoghue, A. M. (2004) · Poultry Science · doi:10.1093/ps/83.12.1944 · Cited by 142
Evolutionary consequences of intra-patient phage predation on microbial populations
Seed, K. D., Yen, M., Shapiro, B. J., Hilaire, I. J., Charles, R. C., Teng, J. E., Ivers, L. C., Boncy, J., Harris, J. B., & Camilli, A. (2014) · eLife · doi:10.7554/elife.03497 · Cited by 142
Phage therapy redux—What is to be done?
Young, R., & Gill, J. J. (2015) · Science · doi:10.1126/science.aad6791 · Cited by 129
Masui, K., Gini, B., Wykosky, J., Zanca, C., Mischel, P. S., Furnari, F. B., & Cavenee, W. K. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt086 · Cited by 128
Ram, G., Chen, J. Y.-S., Kumar, K., Ross, H. F., Úbeda, C., Damle, P. K., Lane, K. D., Penadés, J. R., Christie, G. E., & Novick, R. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204615109 · Cited by 127
Verma, V., Harjai, K., & Chhibber, S. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp360 · Cited by 120
Kirby, A. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051017 · Cited by 116
Cooperation, Quorum Sensing, and Evolution of Virulence in Staphylococcus aureus
Pollitt, E. J. G., West, S. A., Crusz, S. A., Burton-Chellew, M. N., & Diggle, S. P. (2013) · Infection and Immunity · doi:10.1128/iai.01216-13 · Cited by 109
Betts, A., Vasse, M., Kaltz, O., & Hochberg, M. (2013) · Evolutionary Applications · doi:10.1111/eva.12085 · Cited by 102
Self-citationMcVicker, G., Prajsnar, T. K., Williams, A., Wagner, N., Boots, M., Renshaw, S. A., & Foster, S. J. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003959 · Cited by 100
Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms
Zhang, Q., & Buckling, A. (2012) · Evolutionary Applications · doi:10.1111/j.1752-4571.2011.00236.x · Cited by 99
Fluoroquinolone induction of phage-mediated gene transfer in multidrug-resistant Salmonella
Bearson, B. L., & Brunelle, B. W. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.04.008 · Cited by 95
Antibiotic Treatment Selects for Cooperative Virulence of Salmonella Typhimurium
Diard, M., Sellin, M. E., Dolowschiak, T., Arnoldini, M., Ackermann, M., & Hardt, W. (2014) · Current Biology · doi:10.1016/j.cub.2014.07.028 · Cited by 95
The path of least resistance: aggressive or moderate treatment?
Kouyos, R. D., Metcalf, C. J. E., Birger, R. B., Klein, E. Y., Wiesch, P. A. Z., Ankomah, P., Arinaminpathy, N., Bogich, T. L., Bonhoeffer, S., Brower, C. H., et al. (2014) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2014.0566 · Cited by 88
Bacteriophage therapies re-enter clinical trials
Kingwell, K. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4695 · Cited by 79
Main features on tailed phage, host recognition and DNA uptake
Letellìer, L. (2004) · Frontiers in bioscience · doi:10.2741/1333 · Cited by 77
Poverty and Root Causes of Resistance in Developing Countries
Okeke, I. N. (2009) · Springer eBooks · doi:10.1007/978-0-387-89370-9_3 · Cited by 48
The potential impact of coinfection on antimicrobial chemotherapy and drug resistance
Birger, R. B., Kouyos, R. D., Cohen, T., Griffiths, E. C., Huijben, S., Mina, M. J., Volkova, V. V., Grenfell, B. T., & Metcalf, C. J. E. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.05.002 · Cited by 46
Aligning Antimicrobial Drug Discovery with Complex and Redundant Host-Pathogen Interactions
Lebeis, S. L., & Kalman, D. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.01.008 · Cited by 24
Cited by
Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria
Kortright, K. E., Chan, B. K., Koff, J. L., & Turner, P. E. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.014 · Cited by 1,212
Phage Therapy in the Postantibiotic Era
Gordillo Altamirano, F. L., & Barr, J. J. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00066-18 · Cited by 998
Resistance Development to Bacteriophages Occurring during Bacteriophage Therapy
Oechslin, F. (2018) · Viruses · doi:10.3390/v10070351 · Cited by 594
Pirnay, J.-P., Djebara, S., Steurs, G., Griselain, J., Cochez, C., De Soir, S., Glonti, T., Spiessens, A., Vanden Berghe, E., Green, S., et al. (2024) · Nature Microbiology · doi:10.1038/s41564-024-01705-x · Cited by 474
Gu Liu, C., Green, S. I., Min, L., Clark, J. R., Salazar, K. C., Terwilliger, A. L., Kaplan, H. B., Trautner, B. W., Ramig, R. F., & Maresso, A. W. (2020) · mBio · doi:10.1128/mbio.01462-20 · Cited by 409
Metadata
- Authors
- Torres-Barceló, C., & Hochberg, M. E.
- Venue
- Trends in Microbiology
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 24
- Issue
- 4
- Pages
- 249-256
- ISSN
- 0966-842X (ISSN-L)
- OpenAlex
- W2274519180
- Cited by
- 308
- References
- 53
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.